Editorial: Towards targeting prolactin signaling in human diseases: stimulate or inhibit?

Front Endocrinol (Lausanne). 2023 Jun 29:14:1213895. doi: 10.3389/fendo.2023.1213895. eCollection 2023.

¹ Université Paris Cité, Paris, Île-de-France, France.
² PRL/GH Pathophysiology, Institut National de la Santé et de la Recherche Médicale (INSERM) U1151 Institut Necker Enfants Malades, Paris, Île-de-France, France.
³ Laboratory of Pituitary Regulation, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Institute of Biology and Experimental Medicine (IBYME), Buenos Aires, Argentina.
⁴ Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
⁵ Centre for Neuroendocrinology, Division of Health Sciences, University of Otago, Dunedin, Otago, New Zealand.

No abstract available

Keywords: behaviour; cancer; disease; inflammation; metabolism; pituitary; prolactin; therapy.

Publication types